The new company aims to combine with a growth-oriented life sciences business with novel products to treat unmet medical needs. Big Cypress is led by CEO and CFO Samuel J. Reich alongside Non-Executive Chairman Jeffrey G. Spragens.
Total SPAC deal count for 2021 year-to-date is now 30 with $7.3 billion in gross proceeds raised. This offering is expected to close on Thursday, January 14.
Ladenburg Thalmann & Co. Inc. is acting as sole book-running manager of the offering. Brookline Capital Markets, a division of Arcadia Securities, LLC, is acting as co-manager of the offering. Dentons US LLP is serving as Issuer’s Counsel with Graubard Miller serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company LLC is acting as trustee.